Analabs Resources Berhad Yönetim

Yönetim kriter kontrolleri 4/4

Analabs Resources Berhad's CEO is Mun Kan, appointed in Apr 2022, has a tenure of 2.58 years. directly owns 4.63% of the company’s shares, worth MYR8.72M. The average tenure of the management team and the board of directors is 16.9 years and 6.5 years respectively.

Anahtar bilgiler

Mun Kan

İcra Kurulu Başkanı

RM 18.0k

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	2.6yrs
CEO sahipliği	4.6%
Yönetim ortalama görev süresi	16.9yrs
Yönetim Kurulu ortalama görev süresi	6.5yrs

Son yönetim güncellemeleri

Recent updates

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Jan 04

Analabs Resources Berhad (KLSE:ANALABS) Is Due To Pay A Dividend Of MYR0.02

Feb 13

Analabs Resources Berhad (KLSE:ANALABS) Is Doing The Right Things To Multiply Its Share Price

Mar 28

Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet

Jan 21

Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly

Sep 13

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

May 24

Analabs Resources Berhad (KLSE:ANALABS) Might Be Having Difficulty Using Its Capital Effectively

Apr 28

Here's Why We Think Analabs Resources Berhad (KLSE:ANALABS) Is Well Worth Watching

Apr 07

Could Analabs Resources Berhad (KLSE:ANALABS) Have The Makings Of Another Dividend Aristocrat?

Mar 17

Should You Buy Analabs Resources Berhad (KLSE:ANALABS) For Its Upcoming Dividend?

Feb 19

CEO

Mun Kan (44 yo)

2.6yrs

Görev süresi

RM 18,000

Tazminat

Mr. Mun Hoow Kan was Junior Engineer Resources Conservation Sdn Bhd from 2002 to 2007. Mr. Kan joined Coveright Surfaces Malaysia Sdn Bhd on December 1, 2010 as Technical Services Engineer on 1 December 20...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Yow Kan	Executive Chairman	25yrs	RM 36.78k	67.08% MYR 126.4m
Mun Kan	Group CEO & Executive Director	2.6yrs	RM 18.00k	4.63% MYR 8.7m
Nyuk Lai	Finance Manager	11.8yrs	Veri yok	1.84% MYR 3.5m
Cynthia Louis	Company Secretary	22yrs	Veri yok	Veri yok
Mei Ling Chew	Company Secretary	22yrs	Veri yok	Veri yok

16.9yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: ANALABS's management team is seasoned and experienced (16.9 years average tenure).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Yow Kan	Executive Chairman	25yrs	RM 36.78k	67.08% MYR 126.4m
Mun Kan	Group CEO & Executive Director	7.7yrs	RM 18.00k	4.63% MYR 8.7m
Clifton Fernandez	Senior Independent Non-Executive Director	8.8yrs	RM 18.00k	Veri yok
Meei Lye	Independent & Non-Executive Director	5.3yrs	RM 12.00k	Veri yok
Yee Chia	Independent & Non Executive Director	2.5yrs	RM 12.00k	Veri yok
Hua Ling	Non-Executive Independent Director	less than a year	Veri yok	Veri yok

6.5yrs

Ortalama Görev Süresi

47yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ANALABS's board of directors are considered experienced (6.5 years average tenure).

Analabs Resources Berhad Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Analabs Resources Berhad, Annual General Meeting, Oct 10, 2024

Analabs Resources Berhad Appoints Ling Hua Kang as Independent and Non Executive Member of Remuneration Committee

Analabs Resources Berhad Appoints Mr. Ling Hua Kang as Independent and Non Executive Independent Director

Analabs Resources Berhad, Annual General Meeting, Oct 04, 2023

Analabs Resources Berhad Announces Cessation of Office of Mr. Lai Yew Choong as Independent and Non Executive Member of Risk Committee

Insufficient new directors

Recent updates

First quarter 2025 earnings released: EPS: RM0.051 (vs RM0.036 in 1Q 2024)

Analabs Resources Berhad, Annual General Meeting, Oct 10, 2024

Full year 2024 earnings released: EPS: RM0.25 (vs RM0.21 in FY 2023)

Third quarter 2024 earnings released: EPS: RM0.026 (vs RM0.012 in 3Q 2023)

Analabs Resources Berhad Appoints Ling Hua Kang as Independent and Non Executive Member of Remuneration Committee

Upcoming dividend of RM0.021 per share

Analabs Resources Berhad Declares an Single Tier Interim Dividend for the Financial Year Ending 30 April 2024, Payable on 22 March 2024

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

New major risk - Financial position

Analabs Resources Berhad Reports Write Offs for the Quarter Ended October 31, 2023

Analabs Resources Berhad Declares Interim Dividend for the Financial Year Ending 30 April 2024

Analabs Resources Berhad Appoints Mr. Ling Hua Kang as Independent and Non Executive Independent Director

Full year 2023 earnings released: EPS: RM0.21 (vs RM0.27 in FY 2022)

Analabs Resources Berhad, Annual General Meeting, Oct 04, 2023

Full year 2023 earnings released: EPS: RM0.21 (vs RM0.27 in FY 2022)

Third quarter 2023 earnings released: EPS: RM0.012 (vs RM0.098 in 3Q 2022)

Upcoming dividend of RM0.02 per share at 1.4% yield

Analabs Resources Berhad (KLSE:ANALABS) Is Due To Pay A Dividend Of MYR0.02

Analabs Resources Berhad Declares Interim Dividend for the Financial Year Ending 30 April 2023, Payable on 10 March 2023

Second quarter 2023 earnings released: EPS: RM0.051 (vs RM0.063 in 2Q 2022)

Analabs Resources Berhad Declares Single Tier Interim Dividend for the Financial Year Ending 30 April 2023

Analabs Resources Berhad Announces Cessation of Office of Mr. Lai Yew Choong as Independent and Non Executive Member of Risk Committee

Insufficient new directors

Analabs Resources Berhad, Annual General Meeting, Oct 05, 2022

Analabs Resources Berhad Appoints Chia Yee Yan as Independent and Non Executive Member of Audit Committee

Full year 2022 earnings released: EPS: RM0.27 (vs RM0.15 in FY 2021)

Analabs Resources Berhad Appoints Chia Yee Yan as Independent and Non Executive Director

Analabs Resources Berhad Re-Designates Kan Mun Hoow as Chief Executive Officer, Effective from 1 April 2022

Analabs Resources Berhad (KLSE:ANALABS) Is Doing The Right Things To Multiply Its Share Price

Third quarter 2022 earnings released: EPS: RM0.098 (vs RM0.051 in 3Q 2021)

Upcoming dividend of RM0.02 per share

Analabs Resources Berhad Announces Single-Tier Interim Dividend for the Period Ending April 30, 2022, Payable on March 11, 2022

Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly

Full year 2021 earnings released: EPS RM0.15 (vs RM0.067 in FY 2020)

Full year 2021 earnings released

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Analabs Resources Berhad (KLSE:ANALABS) Might Be Having Difficulty Using Its Capital Effectively

Here's Why We Think Analabs Resources Berhad (KLSE:ANALABS) Is Well Worth Watching

Third quarter 2021 earnings released: EPS RM0.051 (vs RM0.012 in 3Q 2020)

Could Analabs Resources Berhad (KLSE:ANALABS) Have The Makings Of Another Dividend Aristocrat?

New 90-day low: RM1.10

Should You Buy Analabs Resources Berhad (KLSE:ANALABS) For Its Upcoming Dividend?

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

New 90-day high: RM1.19

Is Analabs Resources Berhad (KLSE:ANALABS) Set To Make A Turnaround?

Second quarter 2021 earnings released: EPS RM0.022

Is Analabs Resources Berhad (KLSE:ANALABS) An Attractive Dividend Stock?

New 90-day high: RM1.22

Analabs Resources Berhad Announces the Resignation of TAN AI PENG as Company Secretary

First quarter earnings released

Full year earnings released - EPS RM0.067

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş